C-MER Eye Care Invests in Biotech Firm Health Hope Pharma

C-MER Eye Care Holdings Limited (HK:3309) has released an update.

C-MER Medical Group, a subsidiary of C-MER Eye Care Holdings Limited, has announced a $1 million investment in Health Hope Pharma as part of a Series A funding round. This investment will result in C-MER holding approximately 23% of Health Hope Pharma’s shares, a clinical-stage biotech company focused on developing oral anti-cancer drugs. This strategic move aligns with C-MER’s growth plans and expands its presence in the biotech sector.

For further insights into HK:3309 stock, check out TipRanks’ Stock Analysis page.